Xiaofan Li

Key Laboratory Of Carcinogenesis And Translational Research
Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Non-contrast MRI Radiomics Nomogram for Predicting Recurrence and Progression-Free Survival in Cervical Cancer following Concurrent Chemoradiotherapy.

Non-contrast MRI Radiomics Nomogram for Predicting Recurrence and Progression-Free Survival in Cervical Cancer following Concurrent Chemoradiotherapy.

Journal: Current medical imaging

Published: January 22, 2026

Phase I clinical trial of lobaplatin combined with image-guided volume-modulated arc radiation therapy in locally advanced cervical cancer.

Phase I clinical trial of lobaplatin combined with image-guided volume-modulated arc radiation therapy in locally advanced cervical cancer.

Journal: BMC cancer

Published: January 13, 2026

Prophylactic extended-field radiotherapy with concurrent chemotherapy for locally advanced cervical cancer: a propensity-score matching analysis.

Prophylactic extended-field radiotherapy with concurrent chemotherapy for locally advanced cervical cancer: a propensity-score matching analysis.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: January 07, 2026

Nimotuzumab plus concurrent chemoradiotherapy sequential maintenance treatment for locally advanced cervical squamous cell carcinoma (NOTABLE-306): a multicenter, prospective, randomized, double-blind, placebo-controlled trial.

Nimotuzumab plus concurrent chemoradiotherapy sequential maintenance treatment for locally advanced cervical squamous cell carcinoma (NOTABLE-306): a multicenter, prospective, randomized, double-blind, placebo-controlled trial.

Journal: Journal of gynecologic oncology

Published: June 25, 2025

Phase II study of enlonstobart (SG001), a novel PD-1 inhibitor in patients with PD-L1 positive recurrent/metastatic cervical cancer.

Phase II study of enlonstobart (SG001), a novel PD-1 inhibitor in patients with PD-L1 positive recurrent/metastatic cervical cancer.

Journal: Gynecologic oncology

Published: June 24, 2024

Risk Prediction Model for Radiation-induced Dermatitis in Patients with Cervical Carcinoma Undergoing Chemoradiotherapy.

Risk Prediction Model for Radiation-induced Dermatitis in Patients with Cervical Carcinoma Undergoing Chemoradiotherapy.

Journal: Asian nursing research

Published: January 09, 2024

Acute hematologic toxicity prediction using dosimetric and radiomics features in patients with cervical cancer: does the treatment regimen matter?

Acute hematologic toxicity prediction using dosimetric and radiomics features in patients with cervical cancer: does the treatment regimen matter?

Journal: Frontiers in oncology

Published: January 05, 2024

Application of Recombinant Human Superoxide Dismutase in Radical Concurrent Chemoradiotherapy for Cervical Cancer to Prevent and Treat Radiation-induced Acute Rectal Injury: A Multicenter, Randomized, Open-label, Prospective Trial.

Application of Recombinant Human Superoxide Dismutase in Radical Concurrent Chemoradiotherapy for Cervical Cancer to Prevent and Treat Radiation-induced Acute Rectal Injury: A Multicenter, Randomized, Open-label, Prospective Trial.

Journal: International journal of radiation oncology, biology, physics

Published: December 13, 2023

Platelet-rich plasma-derived exosomes enhance mesenchymal stem cell paracrine function and nerve regeneration potential.

Platelet-rich plasma-derived exosomes enhance mesenchymal stem cell paracrine function and nerve regeneration potential.

Journal: Biochemical and biophysical research communications

Published: December 06, 2023

Pegylated recombinant human granulocyte colony-stimulating factor for primary prophylaxis of neutropenia in patients with cervical cancer receiving concurrent chemoradiotherapy: a prospective study.

Pegylated recombinant human granulocyte colony-stimulating factor for primary prophylaxis of neutropenia in patients with cervical cancer receiving concurrent chemoradiotherapy: a prospective study.

Journal: BMC cancer

Published: September 28, 2023

The causal effect and autonomous buffering mechanisms of large-scale internal migration on carbon emissions: evidence from China.

The causal effect and autonomous buffering mechanisms of large-scale internal migration on carbon emissions: evidence from China.

Journal: Environmental science and pollution research international

Published: July 31, 2023

Safety and antitumour activity of cadonilimab, an anti-PD-1/CTLA-4 bispecific antibody, for patients with advanced solid tumours (COMPASSION-03): a multicentre, open-label, phase 1b/2 trial.

Safety and antitumour activity of cadonilimab, an anti-PD-1/CTLA-4 bispecific antibody, for patients with advanced solid tumours (COMPASSION-03): a multicentre, open-label, phase 1b/2 trial.

Journal: The Lancet. Oncology

Published: May 18, 2023

Showing 1-12 of 28

Last Updated: 09/26/2026